Sierra Leone’s HIV response is facing mounting pressure as disruptions in global supply chains continue to threaten the availability of lifesaving HIV commodities across the country.
The National HIV/AIDS Secretariat has raised concerns over growing stockouts of antiretroviral drugs (ARVs) and HIV testing kits, warning that the situation could undermine years of progress made in the country’s fight against the virus.
Director General of the Secretariat, Abdul Rahman Sesay, disclosed that the shortages are directly linked to ongoing global supply chain challenges affecting the procurement and delivery of essential medical commodities.
“We have stock out and all this has to do with the supply chain issues due to some of the challenges globally,” Sesay stated.
Despite the growing concerns, the Secretariat noted that Sierra Leone has continued to record progress in HIV diagnosis and treatment coverage. According to Sesay, the estimated number of people living with HIV in the country has risen to about 81,000, a development he attributed largely to improved testing, better access to treatment, and longer survival rates among patients receiving care.
He revealed that approximately 86 percent of people living with HIV in Sierra Leone are now aware of their status, while 87 percent of diagnosed patients are currently receiving treatment. In addition, about 63 percent have achieved viral suppression, a key milestone in reducing transmission and improving quality of life.
However, health officials warned that the current shortages threaten to slow down critical interventions and weaken ongoing efforts aimed at achieving global HIV treatment targets.
The Secretariat further explained that delays in the arrival of medical supplies have already affected the implementation of several programmes, placing additional strain on local health systems and frontline health workers struggling to manage limited resources.
While commending partners and stakeholders for sustaining support to the country’s HIV response, the Secretariat stressed the urgent need for stronger international cooperation and more resilient supply chain systems to prevent further disruptions.
The warning highlights the fragile state of healthcare systems in many developing countries, where global economic and logistical shocks continue to have direct consequences on access to essential medicines and public health services.